(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine

Catalog No. :
ACDHEY729
CAS No. :
959392-22-4
Molecular Formula :
C18H19NOS
Molecular Weight :
297.42

IUPAC Name:(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine

(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine
IUPAC Name(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine
Molecular FormulaC18H19NOS
Molecular Weight297.42
SMILESCNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CSC=C1
InChI KeyGMHDOCXPDYDKOR-KRWDZBQOSA-N
Synonym(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride;Duloxetine impurity F;(S)-(+)-N-methyl-3-(1-naphthalenyloxy)-3-(3-thienyl)propanamine;Duloxetine EP Impurity F HCl;Duloxetine-7;3-Thiophenepropanamine, N-methyl-γ-(1-naphthalenyloxy)-, (γS);(3S)-N-Methyl-γ-(1-naphthalenyloxy)-3-thiophenepropanamine;Duloxetine EP Impurity FQ: What is Duloxetine EP Impurity F Q: What is the CAS Number of Duloxetine EP Impurity F Q: What is the storage condition of Duloxetine EP Impurity F Q: What are the applications of Duloxetine EP Impurity F
CAS No.959392-22-4

Synthetic Route by SureRoute

1. ACDHEY729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDHEY729 route product structure diagram
    ACDHEY729959392-22-4
Inquiry

2. ACDHEY729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDHEY729 route product structure diagram
    ACDHEY729959392-22-4
Inquiry

Comments (0)